

Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring


Motif Bio Seals Clinical Research Firm Settlement Without Payments


(Sharecast News) - Motif Bio announced on Monday that its subsidiary Motif BioSciences has reached an agreement with its former clinical research orga...


Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%


(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) ...


Motif Bio Teams Up With US Forces To Look Into Iclaprim Use


UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped


Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial